Citation Impact
Citing Papers
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
2013
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Chronic Granulomatous Disease
2012
Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review
2020
Leishmaniasis
2018 Standout
Quinoxaline, its derivatives and applications: A State of the Art review
2014 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Neutrophils at work
2014 Standout
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
Cutaneous leishmaniasis
2007 Standout
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Chemotherapy of Leishmaniasis: Past, Present and Future
2007
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
Vascular disorders of the liver # †
2008 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling
2017
Infections, Antigen-Presenting Cells, T Cells, and Immune Tolerance: Their Role in the Pathogenesis of Immune Thrombocytopenia
2009
In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology
2011
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Haematuria and urolithiasis in patients with haemophilia
2003
The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction
2012
Platelets and the immune continuum
2011 Standout
Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease
2005
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Hereditary thrombophilia as a cause of Budd-Chiari syndrome: A study from Western India
2001
Sickle-cell disease
2010 Standout
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
2003
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Pathogenesis and management of iron toxicity in thalassemia
2010
Invited review: Body condition score and its association with dairy cow productivity, health, and welfare
2009 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Comparison between liposomal formulations of amphotericin B
2016
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
2010
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
2007
Control of Neglected Tropical Diseases
2007 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
Management of arthrofibrosis in haemophilic arthropathy
2010
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Arginine metabolism and nutrition in growth, health and disease
2008 Standout
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004
2005
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Risk factors for glucose intolerance in active acromegaly
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Epigenetic changes by DNA methylation in chronic and intermittent hypoxia
2017 StandoutNobel
The spleen and sickle cell disease: the sick(led) spleen
2014
Is Neutrophil/Lymphocyte Ratio Associated with Subclinical Inflammation and Amyloidosis in Patients with Familial Mediterranean Fever?
2013
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
2006
Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy
2008
Growth Hormone Regulation of p85α Expression and Phosphoinositide 3-Kinase Activity in Adipose Tissue
2007
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery
2019
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
2019 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Adverse reactions to first-line antituberculosis drugs
2006
Advances in leishmaniasis
2005 Standout
Molecular Biology of Erythropoietin
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease
2015
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell‐induced vaso‐occlusion
2016
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management
2012
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell–mediated responses that are differentially sensitive to therapy
2009
Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters
2020 Standout
Guidelines for the management of hemophilia
2012 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Anil Pathare being referenced
Transfusion transmitted diseases in haemophilics from western India.
2000
Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome
2010
Cytokines in Sickle Cell Disease
2003
Hydroxyurea or Chronic Exchange Transfusions in Patients With Sickle Cell Disease
2008
Use of the dual force system to correct chronic knee deformities due to severe haemophilia
2000
Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis
1999
Clinical and laboratory characteristics of patients with sickle-cell and autoimmune/connective tissue diseases
2010
Reduction in labile plasma iron during treatment with deferasirox, a once‐daily oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia
2008
Complications of PORT-A-CATH® in patients with sickle cell disease
2011
Cytokine profile of sickle cell disease in Oman
2004
Rifampicin-induced immune thrombocytopenia
1996
Clinical and molecular findings of chronic granulomatous disease in Oman: family studies
2014
Clinical and Genetic Studies of Familial Hemophagocytic Lymphohistiocytosis in Oman: Need for Early Treatment
2003
Venous Thromboembolism in Young Patients From Western India: A Study
2001
Influence of auto-antibody specificities on the clinical course in patients with chronic and acute ITP
2000
Diabetes in acromegaly--a study of 34 cases.
1997
Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
1995
Surgery in Haemophilia: experience from a centre in India
1998
Plasma LPI in β-Thalassemia Patients before and after Treatment with Deferasirox (Exjade®, ICL670).
2005